These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 14656116

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
    Patel VF, Andis SL, Kennedy JH, Ray JE, Schultz RM.
    J Med Chem; 1999 Jul 15; 42(14):2588-603. PubMed ID: 10411479
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
    Wagner MM, Paul DC, Shih C, Jordan MA, Wilson L, Williams DC.
    Cancer Chemother Pharmacol; 1999 Jul 15; 43(2):115-25. PubMed ID: 9923816
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis of two bioactive natural products: FR252921 and pseudotrienic acid B.
    Amans D, Bellosta V, Cossy J.
    Chemistry; 2009 Jul 15; 15(14):3457-73. PubMed ID: 19219867
    [Abstract] [Full Text] [Related]

  • 8. Novel synthesis, cytotoxic evaluation, and structure-activity relationship studies of a series of alpha-alkylidene-gamma-lactones and lactams.
    Janecki T, Błaszczyk E, Studzian K, Janecka A, Krajewska U, Rózalski M.
    J Med Chem; 2005 May 19; 48(10):3516-21. PubMed ID: 15887960
    [Abstract] [Full Text] [Related]

  • 9. Synthesis of the proposed structure of mucoxin via regio- and stereoselective tetrahydrofuran ring-forming strategies.
    Narayan RS, Borhan B.
    J Org Chem; 2006 Feb 17; 71(4):1416-29. PubMed ID: 16468789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis of cryptophycin 52 using the sharpless asymmetric dihydroxylation: diol to epoxide transformation optimized for a base-sensitive substrate.
    Liang J, Moher ED, Moore RE, Hoard DW.
    J Org Chem; 2000 May 19; 65(10):3143-7. PubMed ID: 10814209
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Three new cryptophycins from Nostoc sp. GSV 224.
    Subbaraju GV, Golakoti T, Patterson GM, Moore RE.
    J Nat Prod; 1997 Mar 19; 60(3):302-5. PubMed ID: 9090872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and cytotoxic activity of gamma-aryl substituted alpha-alkylidene-gamma-lactones and alpha-alkylidene-gamma-lactams.
    Albrecht A, Koszuk JF, Modranka J, Rózalski M, Krajewska U, Janecka A, Studzian K, Janecki T.
    Bioorg Med Chem; 2008 May 01; 16(9):4872-82. PubMed ID: 18396404
    [Abstract] [Full Text] [Related]

  • 18. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C, Teicher BA.
    Curr Pharm Des; 2001 Sep 01; 7(13):1259-76. PubMed ID: 11472266
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Binding of the epoxide cryptophycin analog, LY355703 to albumin and its effect on in vitro antiproliferative activity.
    Schultz RM, Shih C, Wood PG, Harrison SD, Ehlhardt WJ.
    Oncol Rep; 1998 Sep 01; 5(5):1089-94. PubMed ID: 9683814
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.